SALT LAKE CITY, May 13, 2022 /PRNewswire/ --PolarityTE, Inc. (Nasdaq: PTE) today announced that the U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced Therapy (RMAT) ...

Welcome! I offer emotional and physical healing through the human energy field. My work enhances and balances the flow of life force through and around your body. I work with people who are ...

PolarityBio, a clinical-stage biotechnology company focused on addressing unmet needs in wound healing through innovation in ...

The U.S. Food and Drug Administration (FDA) has granted a Regenerative Medicine Advanced Therapy (RMAT) designation to PolarityTE’s PTE SkinTE under the its open investigational new drug application ...